TENX Similar Chart Price Prediction
The price of TENX is predicted to go up -1.11%, based on the high correlation periods with OTEX. The similarity of these two price pattern on the periods is 94.25%.
TENX
OTEX
Down: -1.11%Similarity: 94.25%
TENX Revenue Forecast
TENX EPS Forecast
TENX FAQs
What is bull’s view on TENX?
What is bear's view on TENX?
TENX Analyst's Forecast
David Risinger
Leerink Partners
Buy
2024-10-24
Price Target
$16
Upside
+234.73%
Leerink analyst David Risinger initiated coverage of Tenax Therapeutics with an Outperform rating and $16 price target. The firm expects shares to rise as the investment community comes to better appreciate the company's lead asset, TNX-103, which is in Phase 3 for PH-HFpEF, or pulmonary hypertension due to heart failure with preserved ejection fraction. Further, Leerink argues that key asset TNX-103 has multibillion dollar sales potential, and it forecasts unadjusted worldwide 2036 sales of $2.2B and 30% probability-adjusted sales of $670M.
Seamus Fernandez
Guggenheim
Strong Buy
2024-10-14
Price Target
$16
Upside
+322.16%
Matt Phipps
William Blair
Buy
2024-09-30
Price Target
n/a
Downside
0%
